Literature DB >> 27199453

Heterotrimeric G protein signaling in polycystic kidney disease.

Taketsugu Hama1, Frank Park2.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is a signalopathy of renal tubular epithelial cells caused by naturally occurring mutations in two distinct genes, polycystic kidney disease 1 (PKD1) and 2 (PKD2). Genetic variants in PKD1, which encodes the polycystin-1 (PC-1) protein, remain the predominant factor associated with the pathogenesis of nearly two-thirds of all patients diagnosed with PKD. Although the relationship between defective PC-1 with renal cystic disease initiation and progression remains to be fully elucidated, there are numerous clinical studies that have focused upon the control of effector systems involving heterotrimeric G protein regulation. A major regulator in the activation state of heterotrimeric G proteins are G protein-coupled receptors (GPCRs), which are defined by their seven transmembrane-spanning regions. PC-1 has been considered to function as an unconventional GPCR, but the mechanisms by which PC-1 controls signal processing, magnitude, or trafficking through heterotrimeric G proteins remains to be fully known. The diversity of heterotrimeric G protein signaling in PKD is further complicated by the presence of non-GPCR proteins in the membrane or cytoplasm that also modulate the functional state of heterotrimeric G proteins within the cell. Moreover, PC-1 abnormalities promote changes in hormonal systems that ultimately interact with distinct GPCRs in the kidney to potentially amplify or antagonize signaling output from PC-1. This review will focus upon the canonical and noncanonical signaling pathways that have been described in PKD with specific emphasis on which heterotrimeric G proteins are involved in the pathological reorganization of the tubular epithelial cell architecture to exacerbate renal cystogenic pathways.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  accessory proteins; heterotrimeric G proteins; kidney; polycystic kidney disease; signal transduction

Mesh:

Substances:

Year:  2016        PMID: 27199453      PMCID: PMC4967223          DOI: 10.1152/physiolgenomics.00027.2016

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  206 in total

1.  Activation of Gbetagamma signaling downstream of Wnt-11/Xfz7 regulates Cdc42 activity during Xenopus gastrulation.

Authors:  Alfredo Penzo-Mendèz; Muriel Umbhauer; Alexandre Djiane; Jean-Claude Boucaut; Jean-François Riou
Journal:  Dev Biol       Date:  2003-05-15       Impact factor: 3.582

2.  Activation of heterotrimeric G proteins by Smoothened.

Authors:  Natalia A Riobo; Berangere Saucy; Cherisse Dilizio; David R Manning
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-02       Impact factor: 11.205

Review 3.  Gαq signalling: the new and the old.

Authors:  Guzmán Sánchez-Fernández; Sofía Cabezudo; Carlota García-Hoz; Cristiane Benincá; Anna M Aragay; Federico Mayor; Catalina Ribas
Journal:  Cell Signal       Date:  2014-01-17       Impact factor: 4.315

Review 4.  Activators of G protein signaling in the kidney.

Authors:  Frank Park
Journal:  J Pharmacol Exp Ther       Date:  2015-01-27       Impact factor: 4.030

Review 5.  The prostanoid EP4 receptor and its signaling pathway.

Authors:  Utako Yokoyama; Kousaku Iwatsubo; Masanari Umemura; Takayuki Fujita; Yoshihiro Ishikawa
Journal:  Pharmacol Rev       Date:  2013-06-17       Impact factor: 25.468

6.  The KLHL12-Cullin-3 ubiquitin ligase negatively regulates the Wnt-beta-catenin pathway by targeting Dishevelled for degradation.

Authors:  Stephane Angers; Chris J Thorpe; Travis L Biechele; Seth J Goldenberg; Ning Zheng; Michael J MacCoss; Randall T Moon
Journal:  Nat Cell Biol       Date:  2006-03-19       Impact factor: 28.824

7.  Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial.

Authors:  Loes van Keimpema; Frederik Nevens; Ragna Vanslembrouck; Martijn G H van Oijen; Aswin L Hoffmann; Helena M Dekker; Robert A de Man; Joost P H Drenth
Journal:  Gastroenterology       Date:  2009-07-29       Impact factor: 22.682

8.  Angiotensin AT2 receptor stimulation is anti-inflammatory in lipopolysaccharide-activated THP-1 macrophages via increased interleukin-10 production.

Authors:  Isha Dhande; Wanshu Ma; Tahir Hussain
Journal:  Hypertens Res       Date:  2014-09-11       Impact factor: 3.872

9.  Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial.

Authors:  Anna Caroli; Norberto Perico; Annalisa Perna; Luca Antiga; Paolo Brambilla; Antonio Pisani; Bianca Visciano; Massimo Imbriaco; Piergiorgio Messa; Roberta Cerutti; Mauro Dugo; Luca Cancian; Erasmo Buongiorno; Antonio De Pascalis; Flavio Gaspari; Fabiola Carrara; Nadia Rubis; Silvia Prandini; Andrea Remuzzi; Giuseppe Remuzzi; Piero Ruggenenti
Journal:  Lancet       Date:  2013-08-21       Impact factor: 79.321

10.  Ligand-dependent responses of the ErbB signaling network: experimental and modeling analyses.

Authors:  Marc R Birtwistle; Mariko Hatakeyama; Noriko Yumoto; Babatunde A Ogunnaike; Jan B Hoek; Boris N Kholodenko
Journal:  Mol Syst Biol       Date:  2007-11-13       Impact factor: 11.429

View more
  9 in total

1.  Polycystin 1 loss of function is directly linked to an imbalance in G-protein signaling in the kidney.

Authors:  Bo Zhang; Uyen Tran; Oliver Wessely
Journal:  Development       Date:  2018-03-22       Impact factor: 6.868

Review 2.  Adhesion GPCRs as a paradigm for understanding polycystin-1 G protein regulation.

Authors:  Robin L Maser; James P Calvet
Journal:  Cell Signal       Date:  2020-04-16       Impact factor: 4.315

3.  Mechanism of tethered agonist-mediated signaling by polycystin-1.

Authors:  Shristi Pawnikar; Brenda S Magenheimer; Ericka Nevarez Munoz; Robin L Maser; Yinglong Miao
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-06       Impact factor: 12.779

Review 4.  Cilia-Localized Counterregulatory Signals as Drivers of Renal Cystogenesis.

Authors:  Rebecca V Walker; Anthony Maranto; Vivek Reddy Palicharla; Sun-Hee Hwang; Saikat Mukhopadhyay; Feng Qian
Journal:  Front Mol Biosci       Date:  2022-06-23

5.  Epigenetic regulation of arginine vasopressin receptor 2 expression by PAX2 and Pax transcription interacting protein.

Authors:  Saji Abraham; Raghavendra Paknikar; Samina Bhumbra; Danny Luan; Madhusudan Venkatareddy; Christopher O'Connor; Markus Bitzer; Robert A Fenton; Toby Hurd; Puneet Garg; Sanjeevkumar R Patel
Journal:  Am J Physiol Renal Physiol       Date:  2021-02-01

6.  The ion channel function of polycystin-1 in the polycystin-1/polycystin-2 complex.

Authors:  Zhifei Wang; Courtney Ng; Xiong Liu; Yan Wang; Bin Li; Parul Kashyap; Haroon A Chaudhry; Alexis Castro; Enessa M Kalontar; Leah Ilyayev; Rebecca Walker; R Todd Alexander; Feng Qian; Xing-Zhen Chen; Yong Yu
Journal:  EMBO Rep       Date:  2019-08-22       Impact factor: 8.807

Review 7.  Insights Into the Molecular Mechanisms of Polycystic Kidney Diseases.

Authors:  Valeriia Y Vasileva; Regina F Sultanova; Anastasia V Sudarikova; Daria V Ilatovskaya
Journal:  Front Physiol       Date:  2021-09-08       Impact factor: 4.566

Review 8.  Natural-derived compounds and their mechanisms in potential autosomal dominant polycystic kidney disease (ADPKD) treatment.

Authors:  Rhubaniya Mahendran; Soo Kun Lim; Kien Chai Ong; Kek Heng Chua; Hwa Chia Chai
Journal:  Clin Exp Nephrol       Date:  2021-07-12       Impact factor: 2.801

9.  Coregulation Analysis of Mechanistic Biomarkers in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Johannes Leierer; Paul Perco; Benedikt Hofer; Susanne Eder; Alexander Dzien; Julia Kerschbaum; Michael Rudnicki; Gert Mayer
Journal:  Int J Mol Sci       Date:  2021-06-26       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.